Ulf Hannelius
Chief Executive Officer at DIAMYD MEDICAL AB
Net worth: 231 097 $ as of 30/04/2024
Network origin in Ulf Hannelius first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 15 | |
Mainly AB
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ulf Hannelius via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal | |
| University of Florida | College/University | Corporate Officer/Principal | |
| University of Uppsala | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Director/Board Member | |
| Royal Institute of Technology | College/University | Graduate Degree | |
| University of Lund | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| Technische Universität Braunschweig | College/University | Graduate Degree | |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Biotechnology | Director/Board Member | |
Joslin Diabetes Center, Inc.
 Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Umecrine AB
 Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | Biotechnology | Founder | |
Rise AB
 Rise AB BiotechnologyHealth Technology Swerea IVF AB develops and implements new technologies and new working methods within a range of sectors focusing on product, process and production development. It also offer in-depth expertise in relation to materials properties and applications for ceramic, polymer and textile materials. The company was founded in 1949 and is headquartered in Molndal, Sweden. | Biotechnology | Director/Board Member | |
| SVENSKA AEROGEL HOLDING AB | Chemicals: Specialty | Director/Board Member | |
| KANCERA AB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| IMMUNE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Axxonen Holding AB | Director/Board Member | ||
Amal Therapeutics SA
 Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Biotechnology | Director/Board Member | |
Aligera AB
 Aligera AB Electric UtilitiesUtilities Aligera AB operates within the wind energy market. The firm generates renewable electricity and onshore wind power. It focuses entirely on the production and sale of electricity, electricity certificates, and guarantees of origin. The company was founded by Jörgen Lars Ingemar Bender in 2009 and is headquartered in Stockholm, Sweden. | Electric Utilities | Director/Board Member | |
| NEXTCELL PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| PHARMIVA AB (PUBL) | Miscellaneous Commercial Services | Director/Board Member | |
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
| Rolf Lufts Stiftelse Foer Diabetesforskning | Director/Board Member | ||
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA. | Biotechnology | Director/Board Member | |
| HITECH & DEVELOPMENT WIRELESS SWEDEN HOLDING AB | Electronic Equipment/Instruments | Director/Board Member | |
Health Solutions AB
 Health Solutions AB Hospital/Nursing ManagementHealth Services Part of BCB Medical Oy, Health Solutions AB operates hospitals. | Hospital/Nursing Management | Chief Executive Officer | |
Divio Holding AB
 Divio Holding AB Data Processing ServicesTechnology Services Divio Holding AB engages in data hosting and processing. The private company is based in Stockholm, Sweden. | Data Processing Services | Director/Board Member | |
| University of Florida Diabetes Institute | Director/Board Member | ||
Earners Alliance Holding AB
 Earners Alliance Holding AB Financial ConglomeratesFinance Earners Alliance Holding AB engages in the investment industry for the gaming market. It also conducts consulting activities within information technology, management, and computer program development. The company was founded in 2013 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
| NORD INSURETECH GROUP AB | Internet Software/Services | Director/Board Member | |
| ONCOZENGE AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member | |
| AADI BIOSCIENCE, INC. | Biotechnology | Director/Board Member | |
| Nenarg AB | Director/Board Member | ||
| Karessa Pharma AB | Director/Board Member | ||
| Nord Nordic Retail & Distribution Holding AB | Director/Board Member | ||
| AstraZeneca R & D Lund | General Counsel |
Statistics
International
| Sweden | 32 |
| United States | 15 |
| United Kingdom | 3 |
| Ireland | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 20 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 4 |
| Technology Services | 4 |
Operational
| Director/Board Member | 104 |
| Corporate Officer/Principal | 21 |
| Independent Dir/Board Member | 17 |
| Chairman | 17 |
| Chief Tech/Sci/R&D Officer | 16 |
Most connected contacts
- Stock Market
- Insiders
- Ulf Hannelius
- Company connections
